MLM Medical Labs Acquires MD Biosciences, Inc.
October 27, 2020
MLM Medical Labs, a Great Point Partners portfolio company, has acquired MD Biosciences, Inc., an Oakdale, Minnesota-based provider of preclinical, translational and clinical-phase contract research services. The deal expands MLM's U.S. footprint and adds immunohistochemistry, preclinical research and histopathology capabilities to its global laboratory platform as part of an integration with recent U.S. additions such as CirQuest Labs.
- Buyers
- MLM Medical Labs, Great Point Partners
- Targets
- MD Biosciences, Inc.
- Platforms
- MLM Medical Labs
- Industry
- Healthcare Services
- Location
- Minnesota, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
MLM Medical Labs Acquires CirQuest Labs
July 9, 2020
Healthcare Services
MLM Medical Labs, a Great Point Partners portfolio company, acquired Memphis-based CirQuest Labs to establish a U.S. presence and create a globally integrated central lab platform. CirQuest — a specialist in assay development, biomarker testing, and central lab services for drug development — will join MLM’s global operations and its founder, Dr. Lisa K. Jennings, will take on a scientific leadership role.
-
Medical Laboratory Diagnostics (MedLabs) Acquires Mercy Diagnostics
April 1, 2019
Healthcare Services
Caymus Equity Partners’ portfolio company Medical Laboratory Diagnostics, LLC (MedLabs) acquired Mercy Diagnostics, Inc., a Mount Laurel, New Jersey clinical diagnostics laboratory. The add-on transaction closed on April 24, 2019 and is MedLabs’ first strategic acquisition since the company’s majority recapitalization in March 2018.
-
LabCorp Acquires MNG Laboratories from HealthEdge
March 4, 2019
Healthcare Services
LabCorp has acquired MNG Laboratories, an Atlanta-based clinical diagnostic provider specializing in neurogenetics and next-generation sequencing, from HealthEdge Investment Partners' Fund II. The acquisition expands LabCorp’s neurology and neurogenetics testing capabilities and makes MNG’s testing services available through LabCorp’s Covance drug development business.
-
ICON plc Acquires MolecularMD Corporation
February 21, 2019
Healthcare Services
ICON plc acquired MolecularMD Corporation, a molecular diagnostic specialty laboratory, to expand ICON's molecular diagnostic testing capabilities—including next-generation sequencing and immunohistochemistry—and strengthen support for oncology drug–diagnostic co-development. The acquisition integrates MolecularMD's central laboratory services and client base into ICON's global laboratory network to support precision medicine programs across clinical development phases.
-
Centers Laboratory LLC Acquires Medical Laboratory Diagnostics (MedLabs) from Caymus Equity Partners
September 1, 2019
Healthcare Services
Centers Laboratory LLC acquired Medical Laboratory Diagnostics, LLC (MedLabs) from Caymus Equity Partners; the transaction closed on September 16, 2019. MedLabs, headquartered in Cedar Knolls, New Jersey, operates 26 patient service centers and provides clinical diagnostic testing to thousands of physician customers.
-
Discovery Life Sciences Acquires ReachBio Research Labs
April 11, 2023
Biotechnology
Discovery Life Sciences has acquired Seattle-based ReachBio Research Labs to expand its cell biology, toxicology and drug screening capabilities. The acquisition strengthens Discovery's preclinical development and multi-omics service offering, enabling customers to access a broader set of predictive cell-based assays for hematologic diseases, immunology, oncology and cell & gene therapy programs.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.